Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
Conditions
- Metastatic Malignant Solid Neoplasm
- Lymphoma
Interventions
- PROCEDURE: Positron Emission Tomography
- RADIATION: Stereotactic Body Radiation Therapy
- DRUG: Zirconium Zr 89-Df-Crefmirlimab
- RADIATION: Intensity Modulated Radiation Therapy
Sponsor
City of Hope Medical Center
Collaborators